Epidemiology and Natural History of Childhood-Acquired Chronic Hepatitis C: A Single-Center Long-Term Prospective

Mariangela Stinco1, Elisa Bartolini1, Piero Veronese2

  • 1From the Liver Unit, Meyer Children's University Hospital, University of Florence, Florence, Italy.

Insights

Childhood hepatitis C virus (HCV) infection is often chronic but curable with modern antiviral therapy. Early treatment in children can prevent advanced liver disease, improving long-term outcomes.

Area of Science:

  • Pediatric Hepatology
  • Viral Epidemiology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection acquired in childhood presents unique epidemiological and long-term outcome considerations.
  • Understanding the natural history of pediatric HCV is crucial for effective management strategies.

Purpose of the Study:

  • To prospectively describe the epidemiology and long-term outcomes of childhood-acquired hepatitis C virus (HCV) infection.
  • To evaluate the effectiveness of antiviral therapies in a pediatric cohort.

Main Methods:

  • A prospective, single-center study included 163 children with chronic HCV infection from 1988 to 2021.
  • Data collected on infection acquisition (vertical vs. horizontal), spontaneous clearance, and treatment outcomes.
  • Follow-up duration ranged from infancy to late adolescence.

Main Results:

  • Most infections were acquired vertically (125/163).
  • Spontaneous clearance of HCV RNA occurred in 20.8% of vertically infected children.
  • Antiviral therapy demonstrated high sustained virological response (SVR) rates (7/8 with pegylated-interferon, 23/24 with direct-acting antivirals).

Conclusions:

  • Childhood HCV infection is often chronic but treatable with current antiviral therapies.
  • Early intervention with antiviral therapy is recommended to prevent the development of advanced liver disease.
  • This study represents the largest prospective cohort of children with chronic HCV infection.
Abstract